Opinion
Oprah Daily on MSNOpinion
The WHO just weighed in on GLP-1 drugs—here’s what it could mean for you
The global health organization now officially backs drugs like Wegovy for obesity management. But it might be more symbolic than anything else.
Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease December 9, 2025 4:15 ...
FDA has given tentative approval to Lupin’s Siponimod tablets, a bioequivalent version of Mayzent, to treat people with ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Industry experts ...
The Well News on MSNOpinion
Tariffs on generic medicines threaten America's security
America learned during the pandemic that it should never depend on our adversaries for our necessities. But if President ...
As the U.S. focuses on beefing up its biopharma manufacturing infrastructure this year, a similar effort toward improved drug ...
PHOENIX — With flu cases rising overseas in countries like the United Kingdom and a new variant identified in Japan, experts warn that the United States could face an earlier flu season this year.
Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets. He has studied how national ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...
The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...
A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...
The Trump administration is reportedly planning to exclude imported generic drugs from tariffs. White House spokesman Kush Desai told the Wall Street Journal that "the administration is not actively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results